Found: 8
Select item for more details and to access through your institution.
Advanced Melanoma: Current Treatment Options, Biomarkers, and Future Perspectives.
- Published in:
- American Journal of Clinical Dermatology, 2018, v. 19, n. 3, p. 303, doi. 10.1007/s40257-017-0325-6
- By:
- Publication type:
- Article
Author Correction: Reversal of pre-existing NGFR-driven tumor and immune therapy resistance.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Representativeness of the Index Lymph Node for Total Nodal Basin in Pathologic Response Assessment After Neoadjuvant Checkpoint Inhibitor Therapy in Patients With Stage III Melanoma.
- Published in:
- 2022
- By:
- Publication type:
- journal article
First-line therapy-stratified survival in BRAF-mutant melanoma: a retrospective multicenter analysis.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 5, p. 765, doi. 10.1007/s00262-019-02311-1
- By:
- Publication type:
- Article
Targeting tumor-associated acidity in cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 9, p. 1331, doi. 10.1007/s00262-018-2195-z
- By:
- Publication type:
- Article
Switch to checkpoint inhibition after targeted therapy at time of progression or during ongoing response: A retrospective single‐centre experience in patients with BRAF‐mutated melanoma.
- Published in:
- Pigment Cell & Melanoma Research, 2020, v. 33, n. 3, p. 498, doi. 10.1111/pcmr.12835
- By:
- Publication type:
- Article
The emergence of neoadjuvant immune‐ over BRAF therapy in melanoma.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 20, p. 3409, doi. 10.1002/cncr.35490
- By:
- Publication type:
- Article
Reversal of pre-existing NGFR-driven tumor and immune therapy resistance.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-17739-8
- By:
- Publication type:
- Article